multipl
sclerosi
ms
chronic
autoimmun
disord
improp
activ
host
immun
system
result
demyelin
lesion
predominantli
brain
spinal
cord
typic
diagnos
young
adult
progress
neurodegener
dramat
impact
qualiti
life
diseas
progress
preval
sever
lut
often
parallel
diseas
progress
collect
symptom
includ
urgenc
frequenc
micturit
incontin
incomplet
empti
hesit
weak
urin
stream
urinari
retent
common
ms
patient
well
patient
neurogen
bladder
neuron
control
bladder
function
coordin
pontin
storag
micturit
center
brain
stem
send
project
region
lumbosacr
spinal
cord
coordin
parasympathet
outflow
detrusor
thought
hyperreflexia
observ
neurogen
bladder
dysfunct
may
result
impair
neuron
connect
area
spinal
cord
pontin
micturit
center
human
ms
multifactori
diseas
role
genet
environment
influenc
one
environment
variabl
may
trigger
immun
respons
selfantigen
viral
infect
virusinduc
model
demyelin
diseas
avail
rare
use
studi
neurogen
bladder
dysfunct
experiment
autoimmun
encephalomyel
eae
rodent
model
ms
use
frequent
studi
neurogen
bladder
dysfunct
initi
inject
myelin
basic
protein
spinal
cord
homogen
adjuv
initi
immun
respons
anim
eae
show
micturit
symptom
common
ms
patient
includ
detrusor
hyperact
shorten
intermicturit
interv
decreas
void
volum
morpholog
chang
fibrosi
bladder
howev
eae
produc
chronic
inflamm
cn
unclear
onset
limit
demyelin
neurodegener
current
therapeut
option
specif
neurogen
bladder
lack
efficaci
poor
patient
adher
antimuscarin
drug
firstlin
treatment
howev
littl
evid
support
efficaci
neurogen
bladder
dysfunct
better
understand
patholog
chang
bladder
innerv
effect
nerv
degener
contractil
mechan
detrusor
lead
develop
muchneed
treatment
option
subset
patient
aim
studi
examin
nerveevok
cholinerg
purinerg
contract
bladder
vitro
use
coronavirusinduc
mous
model
ms
drug
chemic
obtain
sigma
chemic
compani
st
loui
mo
except
darifenacin
gener
gift
pfizer
limit
sandwich
kent
cie
induct
clinic
symptom
score
assess
approv
univers
pennsylvania
institut
anim
care
use
committe
protocol
approv
decemb
bladder
contract
experi
mice
agematch
control
approv
templ
univers
institut
anim
care
use
committe
protocol
approv
august
euthan
anim
via
cervic
disloc
perform
follow
isofluran
anesthesia
accord
recommend
guid
care
use
laboratori
anim
distribut
nation
institut
health
male
mice
wk
age
n
jackson
laboratori
bar
harbor
inject
mous
hepat
viru
mhv
strain
pfu
phosphat
buffer
salin
pb
intracrani
clinic
symptom
score
css
determin
anim
follow
induct
cie
base
follow
observ
normal
clinic
sign
loss
tail
tonicitykyphosi
tail
paralysissever
kyphosi
partial
hind
limb
paralysi
complet
hind
limb
paralysi
complet
hind
limb
paralysi
forelimb
paresisparalysi
model
anim
show
signific
css
score
within
day
css
score
peak
week
postinocul
declin
thu
css
score
determin
anim
css
score
declin
day
usual
second
week
averag
maximum
css
anim
use
studi
major
anim
css
surviv
acut
phase
enceph
two
anim
studi
surviv
peak
css
acut
infect
none
css
demyelin
lesion
cn
appar
time
point
previous
establish
model
howev
observ
demyelin
bladder
wall
week
postinfect
figur
mice
ad
libitum
access
food
water
mice
euthan
week
follow
induct
cie
bladder
harvest
urothelium
submucosa
remov
bladder
mucosa
denud
sharp
dissect
use
surgic
microscop
bladder
cut
longitudin
strip
approxim
mm
wide
mm
long
bladder
strip
suspend
g
tension
tissu
bath
contain
ml
modifi
tyrod
solut
mm
nacl
mm
kcl
mm
mm
mm
mm
mm
glucos
equilibr
follow
equilibr
bath
solut
minut
strip
induc
contract
high
potassium
tyrod
solut
mm
nacl
mm
kcl
mm
mm
mm
mm
mm
glucos
rins
data
collect
comput
use
powerlab
data
acquisit
system
adinstru
inc
colorado
spring
co
strip
incub
minut
presenc
absenc
one
concentr
competit
select
antagonist
methoctramin
n
per
condit
competit
select
antagonist
darifenacin
nm
n
per
condit
dose
respons
curv
deriv
peak
tension
develop
respons
cumul
addit
nonsubtyp
select
muscarin
receptor
agonist
bethanechol
bethanechol
concentr
mm
half
log
interv
use
approxim
minut
interv
next
concentr
bethanechol
either
vehicl
one
concentr
methoctramin
select
antagonist
darifenacin
select
antagonist
use
muscl
strip
dose
ratio
antagonist
treat
strip
determin
base
averag
vehicl
treat
strip
valu
determin
strip
use
sigmoid
curv
fit
data
origin
originlab
corp
northampton
schild
plot
construct
calcul
antagonist
potenc
purinerg
receptor
involv
bladder
contract
known
desensit
rapidli
bladder
strip
expos
concentr
atp
half
log
interv
n
gener
atp
concentr
respons
curv
nerveevok
contract
induc
electr
field
stimul
ef
use
bipolar
platinum
electrod
approxim
cm
apart
orient
along
length
strip
use
stimulu
volt
ms
puls
durat
ef
induc
use
grass
stimul
natu
neurolog
inc
warwich
ri
interfac
stimusplitt
ii
medlab
instrument
loveland
co
power
amplifi
frequenc
respons
curv
construct
strip
hz
strip
allow
equilibr
minut
next
stimul
follow
frequenc
respons
strip
expos
either
atropin
atp
minut
stimul
repeat
second
frequenc
respons
strip
previous
expos
atropin
treat
atp
strip
previous
expos
atp
treat
atropin
minut
third
frequenc
respons
perform
last
treatment
preliminari
experi
show
differ
success
frequenc
respons
curv
absenc
atropin
atp
data
shown
pelvic
organ
agematch
control
mice
cie
mice
harvest
formalinfix
take
care
ensur
bladder
empti
bladder
associ
genitourinari
pelvic
floor
tissu
collect
en
bloc
ie
bladder
attach
genitourinari
structur
muscl
care
separ
vertebra
os
coxa
section
anteriorposterior
block
tissu
equilibr
sucros
phosphat
buffer
day
frozen
cryosect
seri
adjac
section
cut
cryostat
section
thick
mount
onto
charg
slide
superfrost
plu
slide
fisherbrand
dri
section
stain
hematoxylin
eosin
h
e
dehydr
cover
slip
dpx
mount
medium
thick
bladder
layer
urothelium
mucosa
detrusor
muscl
measur
magnif
use
bioquant
softwar
nashvil
tn
three
section
per
bladder
separ
least
analyz
inner
outer
margin
layer
trace
autowidth
tool
bioquant
imag
analysi
program
averag
thick
layer
automat
gener
interv
total
measur
made
per
layer
per
bladder
result
averag
layer
bladder
data
present
mean
sem
individu
comparison
statist
differ
determin
either
student
ttest
nonparametr
statist
wilcoxon
rank
summannwhitney
utest
varianc
group
nonhomogen
determin
statist
differ
multipl
group
analysi
varianc
posthoc
comparison
perform
howev
varianc
group
nonhomogen
nonparametr
statist
wilcoxon
rank
summannwhitney
utest
use
week
postinocul
averag
css
cie
mice
approxim
averag
maximum
css
mice
use
studi
rang
mice
css
maximum
statist
signific
correl
css
score
outcom
measur
studi
includ
potassiuminduc
contract
nervemedi
maxim
contract
bethanecholinduc
maxim
contract
bethanechol
potenc
purinergicinduc
maxim
contract
potenc
atp
percent
purinerg
cholinerg
compon
nerv
mediat
contract
mice
cie
n
weigh
significantli
less
p
control
n
g
respect
wherea
weight
bladder
mice
cie
differ
comparison
bladder
control
mice
mg
mg
respect
subsequ
vitro
contractil
studi
length
weight
bladder
strip
measur
determin
crosssect
area
cxa
figur
differ
cxa
mucosa
denud
cie
mucosa
denud
control
bladder
strip
howev
mucosa
intact
bladder
strip
cxa
significantli
p
greater
bladder
strip
cie
compar
control
mice
suggest
mucos
hypertrophi
muscl
hypertrophi
cie
mice
bladder
histolog
examin
tissu
figur
confirm
signific
increas
thick
submucos
layer
cie
bladder
compar
control
bladder
urotheli
layer
cie
bladder
differ
control
bladder
addit
thick
detrusor
smooth
muscl
layer
similar
cie
control
respect
stain
myelin
basic
protein
observ
within
bladder
wall
pudend
nerv
cie
mice
show
similar
pattern
age
match
control
mice
figur
thu
evid
peripher
demyelin
observ
model
prior
agonist
nerveinduc
contract
studi
bladder
strip
induc
contract
isoton
buffer
contain
mm
potassium
differ
potassiuminduc
maxim
contract
mucosa
denud
bladder
strip
cie
control
mice
either
term
gram
figur
suggest
cie
induc
deficit
abil
muscl
gener
forc
contrast
even
though
maxim
potassiuminduc
contract
term
gram
mucosa
intact
bladder
strip
cie
control
mice
differ
potassiuminduc
contract
significantli
p
less
bladder
strip
cie
mice
compar
control
normal
cxa
reduct
potassium
contract
intact
cie
mous
bladder
strip
may
result
mucos
hypertrophi
henc
increas
cxa
mucosa
intact
bladder
cie
mice
detrusor
smooth
muscl
cie
mice
respond
greater
exogen
bethanechol
age
match
control
mice
figur
show
twofold
greater
contract
cie
denud
vs
age
match
control
denud
strip
normal
cxa
cxa
group
nearli
ident
figur
account
observ
differ
age
match
control
mice
maxim
bethanecholinduc
contract
kcl
significantli
less
mucosa
denud
compar
mucosa
intact
bladder
strip
suggest
mucosa
augment
cholinergicinduc
maxim
contract
control
effect
seen
cie
mous
bladder
potenc
bethanechol
tabl
significantli
increas
lower
cie
bladder
strip
vs
age
match
control
mucosa
intact
mucosa
denud
remov
mucosa
control
cie
mous
bladder
effect
potenc
bethanechol
induc
contract
seen
tabl
subtyp
select
antagonist
darifenacin
highli
potent
inhibit
bethanecholinduc
contract
mucosa
intact
cie
control
bladder
strip
pkb
respect
overlap
confid
interv
consist
muscarin
receptor
mediat
bladder
contract
remov
mucosa
significantli
nonoverlap
confid
interv
increas
darifenacin
potenc
cie
control
bladder
strip
pkb
respect
select
antagonist
methoctramin
low
potenc
inhibit
bethanecholinduc
contract
mucosa
intact
mucosa
denud
cie
control
bladder
tabl
also
consist
muscarin
receptor
mediat
cholinergicinduc
contract
cie
agematch
control
bladder
concentr
respons
curv
receptor
agonist
atp
gener
noncumul
addit
agonist
cie
control
bladder
strip
mucosa
denud
mucosa
intact
differ
maxim
contract
atp
control
cie
bladder
strip
either
mucosa
denud
mucosa
intact
addit
valu
similar
group
rang
figur
nerveevok
contract
induc
ef
use
train
puls
v
ms
puls
durat
vari
frequenc
hz
efsinduc
contract
virtual
elimin
presenc
tetrodotoxin
ttx
blocker
nerv
transmiss
nerv
fiber
confirm
contract
nerveevok
data
shown
differ
maxim
nerveevok
contract
mucosa
intact
bladder
strip
control
cie
mice
figur
b
remov
mucosa
effect
maxim
nerveevok
contract
bladder
strip
cie
mice
howev
remov
mucosa
control
bladder
strip
significantli
reduc
maxim
nerveevok
contract
frequenc
hz
suggest
mucosa
augment
nerveevok
contract
control
cie
bladder
possibl
nervemedi
releas
either
acetylcholin
ach
atp
mucosa
mucosa
intact
bladder
strip
isol
control
mice
nonselect
muscarin
receptor
antagonist
atropin
reduc
nerveevok
maxim
contract
p
figur
solid
squar
lesser
degre
desensit
purinerg
receptor
atp
also
reduc
nerveevok
maxim
contract
p
figur
solid
circl
combin
drug
reduc
nerveevok
maxim
contract
p
shown
confirm
two
neurotransmitt
respons
nearli
nerveevok
contract
remov
mucosa
signific
impact
inhibitori
effect
atropin
atp
figur
b
c
combin
cholinerg
purinerg
compon
nerveevok
contract
quit
differ
mucosa
intact
cie
mous
bladder
strip
purinerg
stimul
figur
open
squar
mediat
cholinerg
stimul
figur
open
circl
mediat
maxim
nerveevok
contract
thu
cholinerg
compon
nerveevok
contract
reduc
p
cie
mous
bladder
purinerg
compon
increas
p
cie
mous
bladder
compar
control
alter
purinerg
cholinerg
compon
nerveevok
muscl
contract
mediat
mucosa
cie
mice
remov
mucosa
cie
mous
bladder
increas
p
cholinerg
compon
nerveevok
contract
figur
open
circl
decreas
p
purinerg
compon
figur
open
squar
mucosa
denud
cie
mous
bladder
rel
magnitud
cholinerg
purinerg
compon
nerveevok
contract
differ
control
figur
b
cie
mice
lead
neurogen
detrusor
overact
recent
character
cystometri
record
awak
unrestrain
anim
reveal
cie
mice
shorten
intermicturit
interv
lower
void
volum
elev
number
nonvoid
contract
comparison
control
although
gross
histolog
analysi
bladder
cie
control
mice
show
substanti
differ
previou
report
detail
quantit
histolog
analysi
bladder
cie
mice
present
demonstr
organlevel
hypertrophi
appear
result
edema
primarili
submucos
layer
granulocyt
observ
lymphocyt
suggest
edema
may
relat
increas
permeabl
rather
inflamm
idea
support
previou
studi
demonstr
increas
urotheli
permeabl
within
sever
hour
spinal
cord
injuri
rat
studi
also
provid
solid
evid
connect
nervou
system
urothelium
support
find
well
examin
chang
motor
innerv
contractil
respons
exogen
agonist
cie
mice
also
determin
role
mucosa
observ
chang
ach
atp
releas
termin
parasympathet
nerv
micturit
howev
rel
contribut
cotransmitt
known
vari
speci
diseas
state
influenc
mucosa
bladder
contract
also
vari
speci
exampl
pig
bladder
mucosa
suppress
contract
wherea
normal
mice
mucosa
potenti
contractil
respons
bethanechol
electr
field
stimul
nerveevok
contract
role
atropin
resist
noncholinerg
compon
normal
bladder
contract
mani
mammal
exclud
man
normal
mice
purinerg
compon
nerveevok
contract
observ
reach
magnitud
approxim
maximum
nerveevok
contract
without
atropin
remov
mucosa
alter
rel
magnitud
either
purinerg
cholinerg
compon
nerveevok
contract
figur
decreas
absolut
magnitud
howev
cie
mice
mucosa
longer
enhanc
magnitud
nerveevok
bethanecholinduc
contract
instead
mucosa
cie
mous
bladder
decreas
cholinerg
compon
nerveevok
contract
augment
purinerg
compon
consist
increas
role
atp
observ
variou
human
bladder
patholog
outlet
obstruct
due
enlarg
prostat
overact
bladder
neurogen
bladder
interstiti
cystiti
previous
mention
human
bladder
strip
show
atropineresist
contract
absenc
patholog
remov
mucosa
cie
mous
bladder
result
nerveevok
contract
similar
mucosa
intact
control
bladder
augment
nerveevok
bethanecholinduc
contract
observ
mucosa
intact
age
match
control
lost
cie
bladder
rather
presenc
mucosa
intact
cie
bladder
decreas
rel
magnitud
cholinerg
compon
enhanc
purinerg
compon
nerveevok
contract
without
alter
magnitud
contractil
respons
therefor
evid
rel
contribut
two
neurotransmitt
influenc
presenc
mucosa
may
part
due
alter
releas
variou
substanc
influenc
smooth
muscl
contract
perhap
alter
interstiti
cell
relay
mucos
signal
smooth
muscl
detrusor
urothelium
known
releas
variou
substanc
ach
atp
nitric
oxid
prostaglandin
nerv
growth
factor
substanc
could
either
inhibitori
augment
effect
muscarin
receptormedi
detrusor
contract
also
evid
mucosalderiv
yet
unidentifi
factor
inhibit
bladder
contract
spermidin
endogen
polycation
amin
act
receptorindepend
fashion
modul
ion
channel
includ
calcium
channel
increas
spermidin
product
releas
shown
cultur
urotheli
cell
patient
overact
bladder
polyamin
includ
spermidin
also
shown
inhibit
achinduc
contract
gastrointestin
smooth
muscl
trigger
relax
achinduc
contract
rat
bladder
whether
alter
urotheli
spermidin
product
releas
mice
bladder
overact
seen
cie
still
unknown
data
suggest
mucos
dysfunct
develop
cie
mous
bladder
dysfunct
may
relat
alter
urotheli
releas
mediat
contract
describ
andor
alter
permeabl
support
edema
found
submucos
layer
creat
organlevel
hypertrophi
addit
chang
express
level
sever
receptor
shown
eae
mice
differ
model
ms
includ
upregul
receptor
transcript
mucosa
detrusor
smooth
muscl
previous
shown
variou
bladder
patholog
increas
role
subtyp
mediat
contract
howev
subtypeselect
antagonist
data
support
role
receptor
predominantli
mediat
contract
also
previous
shown
transcript
densiti
correl
protein
level
across
variou
rat
bladder
patholog
control
cie
bladder
potenc
select
antagonist
darifenacin
increas
remov
mucosa
may
suggest
mucos
receptor
particip
bethanecholinduc
contract
strip
urotheli
receptor
shown
mediat
releas
atp
compound
stimul
ach
releas
urothelium
urotheli
releas
ach
may
act
muscarin
receptor
urotheli
releas
atp
may
act
purinerg
receptor
enhanc
contract
addit
atp
ach
releas
respons
bethanechol
activ
mucos
receptor
would
tend
reduc
darifenacininduc
shift
bethanechol
dose
respons
curv
would
reduc
methoctramineinduc
shift
darifenacin
potenc
increas
similar
degre
upon
remov
mucosa
cie
control
bladder
strip
cie
may
alter
urotheli
modulatori
mechan
hypertrophi
observ
detrusor
smooth
muscl
cie
mice
howev
note
twofold
increas
maximum
respons
nonselect
muscarin
agonist
bethanechol
term
normal
forc
may
result
upregul
muscarin
receptor
detrusor
smooth
muscl
cie
mice
support
increas
bethanechol
potenc
cie
bladder
well
increas
bethanecholinduc
maximum
contract
kcl
denud
cie
vs
control
might
similar
phenomenon
muscarin
supersensit
follow
outlet
obstruct
accumul
lesion
cn
result
cie
mice
ms
human
eventu
disrupt
alter
complex
neuron
control
micturit
cie
mous
model
show
demyelin
primarili
cn
demyelin
peripher
nerv
observ
bladder
wall
yet
distinct
phenotyp
neurogen
bladder
dysfunct
observ
character
increas
number
nonvoid
contract
shorten
intermicturit
interv
symptom
similar
observ
upper
spinal
cord
injuri
suggest
interrupt
caus
msinduc
lesion
result
decreas
central
control
resembl
spinal
cord
injuri
cystometri
find
thought
function
increas
affer
activ
suggest
loss
descend
inhibit
pontin
micturit
center
data
suggest
chang
motor
effer
innerv
well
mucosa
play
signific
role
modul
effer
signal
previou
studi
shown
tight
link
urothelium
nervou
system
number
alter
urotheli
cell
patholog
condit
data
support
idea
studi
requir
definit
conclud
cell
type
alter
mice
examin
chang
bladder
affer
summari
data
demonstr
deficit
nerveevok
cholinerg
compon
contract
cie
mice
due
abil
smooth
muscl
respond
acetylcholin
fact
bethanechol
potenc
maxim
contractil
respons
increas
conclud
neurodegen
bladder
dysfunct
model
multipl
sclerosi
may
part
due
patholog
chang
urothelium
bladder
mucosa
caus
suppress
muscarin
receptormedi
contractil
respons
augment
purinerg
respons
underli
smooth
muscl
